How to predict hearing aid outcomes using AI

This session explores the cutting-edge frontier of inner ear therapeutics. We will cover groundbreaking innovations, including gene therapy for hereditary deafness, regenerative medicine for hair cell restoration, and novel drug delivery systems for treating hearing and balance disorders.

outcome objectives participants will be able to:

1. describe emerging gene and cell-based strategies for hearing restoration.

2. evaluate the potential of next-generation cochlear and vestibular implants.

3. identify new pharmacological targets and delivery methods for the inner ear.

background sensorineural hearing loss and vestibular disorders have long been considered irreversible. Advances in molecular biology and bioengineering are now challenging this paradigm, creating unprecedented opportunities for biological repair and functional restoration of the inner ear.

IFOS educational courses around the world will be discussed.

Randomised control trial comparing a new algorithm to improved discrimination in noise

Description this explores the vital link between hearing preservation and well-being in older adults, emphasizing cognitive and social impacts.

outcome objectives

• identify signs of age-related hearing loss.

• understand its direct connection to cognitive decline.

• implement proactive audiological care strategies.

background unmanaged hearing loss in seniors significantly accelerates isolation, depression, and dementia risk. Early intervention is essential for maintaining a high quality of life and healthy, active aging.